España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Acelyrin
SLRN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Acelyrin (SLRN) Forecast
News
Earnings
Acelyrin (SLRN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Acelyrin (NASDAQ:SLRN) Stock
Acelyrin Stock (NASDAQ: SLRN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 11, 2024
Wells Fargo Maintains Overweight on Acelyrin,...
Benzinga Newsdesk
Macy's, Dave & Buster's, Bausch + Lomb And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Acelyrin shares are trading lower after the c...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Neutral on Ace...
Benzinga Newsdesk
Tuesday, December 10, 2024
Trading Halt: Halt status updated at 4:55:00 ...
Benzinga Newsdesk
ACELYRIN Announces 2b/3 Study Of Izokibep Did...
Benzinga Newsdesk
Trading Halt: Halted at 4:25:00 p.m. ET - Tra...
Benzinga Newsdesk
Thursday, November 14, 2024
HC Wainwright & Co. Maintains Neutral on Acel...
Benzinga Newsdesk
Acelyrin shares are trading lower. The compan...
Benzinga Newsdesk
Wednesday, November 13, 2024
Acelyrin Q3 2024 GAAP EPS $(0.49) Beats $(0.7...
Benzinga Newsdesk
Earnings Scheduled For November 13, 2024
Benzinga Insights
Tuesday, November 12, 2024
Earnings Preview: Acelyrin
Benzinga Insights
Wednesday, October 16, 2024
Wells Fargo Maintains Overweight on Acelyrin,...
Benzinga Newsdesk
Thursday, September 19, 2024
ACELYRIN shares are trading higher after the ...
Benzinga Newsdesk
Acelyrin Announced That Results From Its Glob...
Benzinga Newsdesk
Tuesday, September 10, 2024
Acelyrin Announced That Data From Its Phase 1...
Benzinga Newsdesk
Tuesday, August 20, 2024
Fabrinet Posts Strong Earnings, Joins Amer Sports, Hawaiian Holdings And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Monday, August 19, 2024
Morgan Stanley Maintains Equal-Weight on Acel...
Benzinga Newsdesk
Thursday, August 15, 2024
HC Wainwright & Co. Downgrades Acelyrin to Ne...
Benzinga Newsdesk
Wednesday, August 14, 2024
Acelyrin Cuts Workforce, Deprioritizes Former Lead Drug Izokibep
Vandana Singh
Piper Sandler Maintains Overweight on Acelyri...
Benzinga Newsdesk
Ouster Reports Weak Sales, Joins Brinker International And Other Big Stocks Moving Lower In Wednesday Pre-Market Session
Avi Kapoor
ACELYRIN shares are trading lower after the c...
Benzinga Newsdesk
Tuesday, August 13, 2024
ACELYRIN shares are trading higher after the ...
Benzinga Newsdesk
Acelyrin Q2 2024 GAAP EPS $(0.86) Misses $(0....
Benzinga Newsdesk
ACELYRIN Announces Phase 3 Izokibep Trial Met...
Benzinga Newsdesk
Monday, July 08, 2024
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
ACELYRIN shares are trading higher after Well...
Benzinga Newsdesk
Wells Fargo Upgrades Acelyrin to Overweight, ...
Benzinga Newsdesk
Wednesday, May 22, 2024
HC Wainwright & Co. Maintains Buy on Acelyrin...
Benzinga Newsdesk
Wednesday, May 15, 2024
HC Wainwright & Co. Reiterates Buy on Acelyri...
Benzinga Newsdesk
Thursday, May 09, 2024
HC Wainwright & Co. Maintains Buy on Acelyrin...
Benzinga Newsdesk
ACELYRIN Founder Shao-Lee Lin Steps Down As C...
Benzinga Newsdesk
Monday, April 01, 2024
HC Wainwright & Co. Reiterates Buy on Acelyri...
Benzinga Newsdesk
Friday, March 29, 2024
Acelyrin Q4 EPS $(0.75) Beats $(0.99) Estimat...
Benzinga Newsdesk
Thursday, March 21, 2024
Wells Fargo Maintains Equal-Weight on Acelyri...
Benzinga Newsdesk
Wednesday, March 20, 2024
Investors Cheer Acelyrin's Stock, Its Second Lead Candidate Shows Clinical Benefit In Thyroid Eye Disease Patients
Vandana Singh
HC Wainwright & Co. Reiterates Buy on Acelyri...
Benzinga Newsdesk
Acelyrin shares are trading higher after data...
Benzinga Newsdesk
Acelyrin's Phase 1/2 Data For Lonigutamab In ...
Benzinga Newsdesk
Tuesday, March 12, 2024
HC Wainwright & Co. Reiterates Buy on Acelyri...
Benzinga Newsdesk
Monday, March 11, 2024
Acelyrin shares are trading higher after the ...
Benzinga Newsdesk
Acelyrin's Lead Drug Candidate Hits Primary Goal In Late-Stage Psoriatic Arthritis Study
Vandana Singh
Acelyrin Announces Top-line Results From Its ...
Benzinga Newsdesk
Acelyrin Announces Long-term 32-week Data Fro...
Benzinga Newsdesk
Wednesday, December 13, 2023
Wells Fargo Initiates Coverage On Acelyrin wi...
Benzinga Newsdesk
Friday, December 08, 2023
Citigroup Initiates Coverage On Acelyrin with...
Benzinga Newsdesk
Wednesday, November 29, 2023
Morgan Stanley Maintains Equal-Weight on Acel...
Benzinga Newsdesk
Tuesday, November 28, 2023
Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Jefferies Maintains Buy on Acelyrin, Lowers P...
Benzinga Newsdesk
Show More
